Resultats de la cerca - Michael Ochieng
- Mostrar 1 - 4 resultats de 4
-
1
-
2
Safety and efficacy of paromomycin/miltefosine/liposomal amphotericin B combinations for the treatment of post-kala-azar dermal leishmaniasis in Sudan: A phase II, open label, rand... per Brima M. Younis, Ahmed Musa, Séverine Monnerat, Mohammed Abdelrahim Saeed, Eltahir Awad Gasim Khalil, Anas Ahmed, Mujahid Ahmed Ali, Ali Noureldin, Gina Muthoni Ouattara, Godfrey M. Nyakaya, Samuel Teshome, Truphosa Omollo, Michael Ochieng, Thaddaeus Egondi, Mildred Mmbone, Wan‐Yu Chu, Thomas P. C. Dorlo, Eduard E. Zijlstra, Monique Wasunna, Jorge Alvar, Fabiana Alves
Publicat 2023Artigo -
3
Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions: a randomised, open-label, non-inferiority phase 3 trial per Richard Odame Phillips, J. Robert, Kabiru Mohamed Abass, William A. Thompson, Fred Stephen Sarfo, Wilson Tuah, Godfred Sarpong, Thierry Gateau, Annick Chauty, Raymond Omollo, Michael Ochieng Otieno, Thaddaeus Egondi, Edwin Ampadu, Didier Agossadou, Estelle Marion, Line Ganlonon, Mark Wansbrough‐Jones, J Grosset, John M. MacDonald, Terry Treadwell, Paul Saunderson, Albert Paintsil, Linda Lehman, Michael Frimpong, Nanaa Francisca Sarpong, Raoul Saizonou, Alexandre Tiendrébéogo, Sally-Ann Ohene, Ymkje Stienstra, Kingsley Asiedu, Tjip S. van der Werf, Samuel Osei Mireku, Justice Abotsi, Joseph Ken Adu Poku, Richard Asamoah-Frimpong, Bright Osei-Wusu, Edward Sarpong, Beatrice Konadu, Ernest Opoku, Mark Forson, Mathias Ndogyele, Elizabeth Ofori, Felicity Aboagye, Thomas Berko, George Amofa, Anastasia Nsiah, Joyce Mensah-Bonsu, Joseph Ofori Nyarko, Yaw Ampem Amoako, Elliot Koranteng Tannor, Justice K. Boakye-Appiah, Aloysius Dzigbordi Loglo, Mabel Sarpong-Duah, Bernadette Agbavor, Marie Françoise Ardent, Arnaud Yamadjako, Naomi Adanmado Gersande, Ambroise Adeye, Martial Kindjinou, Akpolan, Gbètogo Maxime Kiki, Espoir Sodjinou, Clémence Guegnard, Sandor-Adrian Klis, Kristien Velding, Till F. Omansen, David Ofori‐Adjei, Sarah Eyangoh, A.J. Knell, William R. Faber
Publicat 2020Artigo -
4
Short oral regimens for pulmonary rifampicin-resistant tuberculosis (TB-PRACTECAL): an open-label, randomised, controlled, phase 2B-3, multi-arm, multicentre, non-inferiority trial per Bern-Thomas Nyang’wa, Catherine Berry, Emil Kazounis, Ilaria Motta, Nargiza Parpieva, Zinaida Tigay, Ronelle Moodliar, Matthew Dodd, Varvara Solodovnikova, Irina Liverko, Shakira Rajaram, Mohammed Rassool, Timothy D. McHugh, Melvin Spigelman, David Moore, Koert Ritmeijer, Philipp du Cros, Katherine Fielding, Erin Da Costa, Nathalie Lachenal, Nicola James, Animesh A. Sinha, Kristen LeBeau, Emma Douch, Pascal Jolivert, Hannah Poulsom, Marion Conijn, Spencer B. King, Hannah Spencer, Emma Cunden, C Batts, Thuy Vuong, Sebastian Dietrich, Melissa McRae, Sidney Wong, Eugene Sun, Morounfolu Olugbosi, Leslie Shanks, Michael D. Hughes, Payam Nahid, Johnstone Kumwenda, Todd J. Lorenz, S. S. Majumdar, C. Robert Horsburgh, Eric L. Nuermberger, Graeme Meintjes, Kathleen D. Eisenach, Christian Lienhardt, Andrew Nunn, Christoph Lange, Laura Park, Charlotte Gatts, Dominic Warren, Robert Kleiman, George Nyangweso, Michael Ochieng, Thaddaeus Egondi, Kevin Onyango, Truphoso Omollo, Raymond Omollo, Joanna Sturgess, Steven Saunders, Elizabeth Allen, Suzanne Gajewski, Valentina Butoescu, Jarmila Hanekova, Coralie Etter, Yerkbulan Kambarov, Siza Mphele, Victoria Sukhinina, Olesya Huzar, А. В. Решетников, Christine Cilliè, Nada Ahmed, Robert Hunt, Corinne Merle, Allanazarova Gulayim, M. Mbenga, Zlikha Saparbaevna Baltasheva, Tleubergen Abdrasuliev, Hasmik Margaryan, Utemuratova Gozzal Urgenishbaevna, Alena Skrahina, Natalia Yatskevich, Dzmitry Viatushka, Tatsiana Apanasevich, Aliaksandr Skrahin, Lynette Duckworth, Cindy Narasimooloo, Ndlovu Ellah Lesego, Sharon Motlhako, Mamomoko Ephenia Mashamaite, Evelyn Mojapelo
Publicat 2023Artigo
Eines de cerca:
Matèries relacionades
Medicine
Pathology
Internal medicine
Randomized controlled trial
Antibiotics
Biology
Environmental health
Microbiology
Rifampicin
Surgery
Tuberculosis
Adverse effect
Aminoglycoside
Biostatistics
Buruli ulcer
Clarithromycin
Clinical endpoint
Clinical trial
Dermatology
Disease
Epidemiology
Gastroenterology
Helicobacter pylori
Leishmaniasis
Miltefosine
Mycobacterium ulcerans
Open label
Paromomycin
Population
Public health